Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information (Tables)

v2.4.0.6
Business Segment Information (Tables)
 9 Months Ended
Nov. 30, 2012
Segment Reporting [Abstract]  
Restructuring charges and unusual items
For the nine months and three months ended November 30, 2012, and November 30, 2011, restructuring charges and unusual items included in operating income consist of:

 
For the Nine Months
Ended November 30,
 
For the Three Months
Ended November 30,
 
2012
 
2011
 
2012
 
2011
(in millions)
 
 
 
 
 
 
 
Cost of Product Sold:
 
 
 
 
 
 
 
Flow through of inventory step-up
$
5.7

 
$
0.8

 
$
3.4

 
$
0.8

Accelerated depreciation
—

 
0.3

 
—

 
—

Cost of Product Sold
5.7

 
1.1

 
3.4

 
0.8

 
 
 
 
 
 
 
 
Selling, General and Administrative Expenses:
 
 
 
 
 
 
 
Transaction and related costs associated with pending and completed acquisitions
17.6

 
—

 
8.5

 
—

Gain on settlement of receivable associated with a prior divestiture
(4.0
)
 
—

 
—

 
—

Net gains on acquisition of Ruffino (excluding gain on obligation from put option of Ruffino shareholder) and related activities
—

 
(4.5
)
 
—

 
(6.6
)
Gain on obligation from put option of Ruffino shareholder
—

 
(2.5
)
 
—

 
(2.5
)
Net gains on CWAE Divestiture and related activities
—

 
(2.2
)
 
—

 
(2.1
)
Other costs
7.3

 
6.3

 
1.9

 
2.1

Selling, General and Administrative Expenses
20.9


(2.9
)
 
10.4

 
(9.1
)
 
 
 
 
 
 
 
 
Restructuring Charges
1.0

 
11.6

 
0.3

 
0.8

 
 
 
 
 
 
 
 
Restructuring Charges and Unusual Items
$
27.6

 
$
9.8

 
$
14.1

 
$
(7.5
)
Segment information
Segment information is as follows:

 
For the Nine Months
Ended November 30,
 
For the Three Months
Ended November 30,
 
2012
 
2011
 
2012
 
2011
(in millions)
 
 
 
 
 
 
 
Constellation Wines and Spirits:
 
 
 
 
 
 
 
Net sales
$
2,100.2

 
$
2,026.2

 
$
766.9

 
$
700.7

Segment operating income
$
490.8

 
$
476.0

 
$
196.5

 
$
172.1

Equity in earnings of equity method investees
$
13.1

 
$
13.8

 
$
14.2

 
$
10.1

Long-lived tangible assets
$
1,107.9

 
$
1,117.9

 
$
1,107.9

 
$
1,117.9

Investment in equity method investees
$
80.6

 
$
76.2

 
$
80.6

 
$
76.2

Total assets
$
7,141.6

 
$
6,864.1

 
$
7,141.6

 
$
6,864.1

Capital expenditures
$
45.3

 
$
36.0

 
$
14.6

 
$
10.1

Depreciation and amortization
$
67.8

 
$
63.9

 
$
23.5

 
$
21.5

 
 
 
 
 
 
 
 
Corporate Operations and Other:
 
 
 
 
 
 
 
Net sales
$
—

 
$
—

 
$
—

 
$
—

Segment operating loss
$
(67.7
)
 
$
(59.1
)
 
$
(23.6
)
 
$
(19.3
)
Long-lived tangible assets
$
128.8

 
$
133.8

 
$
128.8

 
$
133.8

Total assets
$
1,035.2

 
$
214.1

 
$
1,035.2

 
$
214.1

Capital expenditures
$
6.9

 
$
18.1

 
$
2.0

 
$
4.8

Depreciation and amortization
$
20.7

 
$
16.7

 
$
7.8

 
$
6.8

 
 
 
 
 
 
 
 
Crown Imports:
 
 
 
 
 
 
 
Net sales
$
2,059.9

 
$
1,945.0

 
$
547.4

 
$
540.5

Segment operating income
$
345.4

 
$
332.1

 
$
79.0

 
$
86.7

Long-lived tangible assets
$
8.8

 
$
6.1

 
$
8.8

 
$
6.1

Total assets
$
350.8

 
$
338.5

 
$
350.8

 
$
338.5

Capital expenditures
$
0.8

 
$
2.8

 
$
0.4

 
$
0.4

Depreciation and amortization
$
2.0

 
$
1.6

 
$
0.5

 
$
0.6

 
 
 
 
 
 
 
 
Restructuring Charges and Unusual Items:
 
 
 
 
 
 
 
Operating loss
$
(27.6
)
 
$
(9.8
)
 
$
(14.1
)
 
$
7.5

Equity in losses of equity method investees
$
(0.2
)
 
$
—

 
$
(0.2
)
 
$
—

 
 
 
 
 
 
 
 
Consolidation and Eliminations:
 
 
 
 
 
 
 
Net sales
$
(2,059.9
)
 
$
(1,945.0
)
 
$
(547.4
)
 
$
(540.5
)
Operating income
$
(345.4
)
 
$
(332.1
)
 
$
(79.0
)
 
$
(86.7
)
Equity in earnings of Crown Imports
$
170.7

 
$
165.7

 
$
38.5

 
$
43.2

Long-lived tangible assets
$
(8.8
)
 
$
(6.1
)
 
$
(8.8
)
 
$
(6.1
)
Investment in equity method investees
$
145.9

 
$
147.0

 
$
145.9

 
$
147.0

Total assets
$
(204.9
)
 
$
(191.5
)
 
$
(204.9
)
 
$
(191.5
)
Capital expenditures
$
(0.8
)
 
$
(2.8
)
 
$
(0.4
)
 
$
(0.4
)
Depreciation and amortization
$
(2.0
)
 
$
(1.6
)
 
$
(0.5
)
 
$
(0.6
)
 
 
 
 
 
 
 
 
 
For the Nine Months
Ended November 30,
 
For the Three Months
Ended November 30,
 
2012
 
2011
 
2012
 
2011
(in millions)
 
 
 
 
 
 
 
Consolidated:
 
 
 
 
 
 
 
Net sales
$
2,100.2

 
$
2,026.2

 
$
766.9

 
$
700.7

Operating income
$
395.5

 
$
407.1

 
$
158.8

 
$
160.3

Equity in earnings of equity method investees
$
183.6

 
$
179.5

 
$
52.5

 
$
53.3

Long-lived tangible assets
$
1,236.7

 
$
1,251.7

 
$
1,236.7

 
$
1,251.7

Investment in equity method investees
$
226.5

 
$
223.2

 
$
226.5

 
$
223.2

Total assets
$
8,322.7

 
$
7,225.2

 
$
8,322.7

 
$
7,225.2

Capital expenditures
$
52.2

 
$
54.1

 
$
16.6

 
$
14.9

Depreciation and amortization
$
88.5

 
$
80.6

 
$
31.3

 
$
28.3